Cadila Healthcare Ltd (CADILAHC):企業の財務・戦略的SWOT分析

【英語タイトル】Cadila Healthcare Ltd (CADILAHC) - Financial and Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(DATA904C2513)・商品コード:DATA904C2513
・発行会社(調査会社):GlobalData
・発行日:2018年7月
・ページ数:58
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Cadila Healthcare Ltd (CADILAHC) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cadila Healthcare Ltd (Zydus Cadila) is an integrated, global healthcare provider. It discovers, develops, manufactures and markets various healthcare products. The company’s product portfolio includes active pharmaceutical ingredients (APIs), formulations, wellness and animal health products. Zydus Cadila’s products find application in the treatment of diseases in the therapeutic areas of gastrointestinal, cardiovascular, respiratory, pain management, cancer, inflammation, neurology, and women’s health, among others. It conducts research to develop biologics, vaccines and new chemical entities. The company has manufacturing facilities in Brazil and India. It has presence in the US, Europe, South Africa, Japan, Brazil, and other emerging markets. Zydus Cadila is headquartered in Ahmedabad, Gujarat, India.

Cadila Healthcare Ltd Key Recent Developments

Jun 06,2018: Cadila Healthcare: USFDA inspection of wholly-owned subsidiary, Alidac Pharmaceuticals Ltd., located at SEZ, Ahmedabad
May 25,2018: Zydus Cadila’s Net Profit up by 53% in Q4
Mar 28,2018: Cadila Healthcare announces successfully completion of USFDA inspection at Topical facility
Mar 17,2018: Zydus receives final approval from the USFDA for Omeprazole and Sodium Bicarbonate Capsules
Feb 09,2018: Cadila Healthcare’s Moraiya facility successfully completes USFDA inspection

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Cadila Healthcare Ltd – Key Facts 6
Cadila Healthcare Ltd – Key Employees 7
Cadila Healthcare Ltd – Key Employee Biographies 8
Cadila Healthcare Ltd – Major Products and Services 9
Cadila Healthcare Ltd – History 11
Cadila Healthcare Ltd – Company Statement 18
Cadila Healthcare Ltd – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 23
Section 2 – Company Analysis 25
Company Overview 25
Cadila Healthcare Ltd – Business Description 26
Business Segment: Animal Health 26
Overview 26
Performance 26
Business Segment: APIs 26
Overview 26
Overview 26
Performance 26
Business Segment: Consumer Wellness 26
Overview 26
Performance 26
Key Stats 27
Business Segment: Formulations 27
Overview 27
Performance 27
Geographical Segment: India 28
Performance 28
Geographical Segment: The US 28
Performance 28
R&D Overview 28
Cadila Healthcare Ltd – SWOT Analysis 29
SWOT Analysis – Overview 29
Cadila Healthcare Ltd – Strengths 29
Cadila Healthcare Ltd – Weaknesses 30
Cadila Healthcare Ltd – Opportunities 31
Cadila Healthcare Ltd – Threats 32
Cadila Healthcare Ltd – Key Competitors 33
Section 3 – Company Financial Ratios 34
Financial Ratios – Capital Market Ratios 34
Financial Ratios – Annual Ratios 35
Performance Chart 38
Financial Performance 38
Financial Ratios – Interim Ratios 39
Financial Ratios – Ratio Charts 40
Section 4 – Company’s Lifesciences Financial Deals and Alliances 41
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 41
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 42
Cadila Healthcare Ltd, Recent Deals Summary 43
Section 5 – Company’s Recent Developments 44
Jun 06, 2018: Cadila Healthcare: USFDA inspection of wholly-owned subsidiary, Alidac Pharmaceuticals Ltd., located at SEZ, Ahmedabad 44
May 25, 2018: Zydus Cadila’s Net Profit up by 53% in Q4 45
Mar 17, 2018: Zydus receives final approval from the USFDA for Omeprazole and Sodium Bicarbonate Capsules 46
Feb 09, 2018: Cadila Healthcare’s Moraiya facility successfully completes USFDA inspection 47
Feb 08, 2018: Zydus Cadila’s EBIDTA up by 108% in Q3 48
Feb 07, 2018: Zydus Wellness’ Consolidated Net profit up by 43.8% in Q3 49
Nov 29, 2017: New diagnostic kits developed to detect rare and neglected infectious diseases 50
Nov 14, 2017: Zydus Cadila’s EBIDTA up by 68% in Q2 51
Sep 07, 2017: Cadila Healthcare’s Moraiya facility successfully completes USFDA inspection 52
Aug 29, 2017: Zydus receives EIR Report for Manufacturing Facility at the Pharma SEZ at Ahmedabad 53
Section 6 – Appendix 54
Methodology 54
Ratio Definitions 54
About GlobalData 58
Contact Us 58
Disclaimer 58

List of Tables
Cadila Healthcare Ltd, Key Facts 6
Cadila Healthcare Ltd, Key Employees 7
Cadila Healthcare Ltd, Key Employee Biographies 8
Cadila Healthcare Ltd, Major Products and Services 9
Cadila Healthcare Ltd, History 11
Cadila Healthcare Ltd, Other Locations 21
Cadila Healthcare Ltd, Subsidiaries 21
Cadila Healthcare Ltd, Joint Venture 23
Cadila Healthcare Ltd, Key Competitors 33
Cadila Healthcare Ltd, Ratios based on current share price 34
Cadila Healthcare Ltd, Annual Ratios 35
Cadila Healthcare Ltd, Annual Ratios (Cont...1) 36
Cadila Healthcare Ltd, Annual Ratios (Cont...2) 37
Cadila Healthcare Ltd, Interim Ratios 39
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 41
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 42
Cadila Healthcare Ltd, Recent Deals Summary 43
Currency Codes 54
Capital Market Ratios 54
Equity Ratios 55
Profitability Ratios 55
Cost Ratios 56
Liquidity Ratios 56
Leverage Ratios 57
Efficiency Ratios 57

List of Figures
Cadila Healthcare Ltd, Performance Chart (2014 - 2018) 38
Cadila Healthcare Ltd, Ratio Charts 40
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 41
Cadila Healthcare Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 42

★調査レポート[Cadila Healthcare Ltd (CADILAHC):企業の財務・戦略的SWOT分析] (コード:DATA904C2513)販売に関する免責事項を必ずご確認ください。
★調査レポート[Cadila Healthcare Ltd (CADILAHC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆